YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role

YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role

Primary liver cancer comprises a diverse group of liver tumors. The heterogeneity of these tumors is seen as one of the obstacles to finding an effective therapy. The Hippo pathway, with its downstream transcriptional co-activator Yes-associated protein (YAP) and transcriptional co-activator with PD...

Spremljeno u:

Bibliografski detalji
Glavni autori:	Matthias Van Haele, Iván M. Moya, Ruçhan Karaman, Guy Rens, J. Snoeck, Olivier Govaere, Frederik Nevens, Chris Verslype, Baki Topal, Diethard Monbaliu, Georg Halder, Tania Roskams
Format:	Artigo
Jezik:	engleski
Izdano:	2019
Online pristup:	https://doi.org/10.3390/ijms20030638 https://www.mdpi.com/1422-0067/20/3/638/pdf?version=1549024629
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!

Slični predmeti

YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role
od: Van Haele, Matthias, i dr.
Izdano: (2019)

Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice
od: Iván M. Moya, i dr.
Izdano: (2019)

High‐throughput sequencing identifies aetiology‐dependent differences in ductular reaction in human chronic liver disease
od: Olivier Govaere, i dr.
Izdano: (2018)

The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma
od: Olivier Govaere, i dr.
Izdano: (2017)

Human Liver Regeneration: An Etiology Dependent Process
od: Van Haele, Matthias, i dr.
Izdano: (2019)

Human Liver Regeneration: An Etiology Dependent Process
od: Matthias Van Haele, i dr.
Izdano: (2019)

YAP/TAZ Orchestrate VEGF Signaling during Developmental Angiogenesis
od: Xiaohong Wang, i dr.
Izdano: (2017)

Regeneration Defects in Yap and Taz Mutant Mouse Livers Are Caused by Bile Duct Disruption and Cholestasis
od: Elisabeth Verboven, i dr.
Izdano: (2020)

Cell Junctions in Hippo Signaling
od: Karaman, Ruchan, i dr.
Izdano: (2018)

Cell Junctions in Hippo Signaling
od: Ruçhan Karaman, i dr.
Izdano: (2017)

Age Matching of Elderly Liver Grafts With Elderly Recipients Does Not Have a Synergistic Effect on Long-term Outcomes When Both Are Carefully Selected
od: Gilbo, Nicholas, i dr.
Izdano: (2019)

YAP/TAZ at the roots of cancer
od: Zanconato, Francesca, i dr.
Izdano: (2016)

YAP/TAZ at the Roots of Cancer
od: Francesca Zanconato, i dr.
Izdano: (2016)

Roles of YAP/TAZ in ferroptosis
od: Suchitra Magesh, i dr.
Izdano: (2022)

Septuagenarian and Octogenarian Donors Provide Excellent Liver Grafts for Transplantation
od: Tom Darius, i dr.
Izdano: (2012)

The emerging roles of YAP and TAZ in cancer
od: Moroishi, Toshiro, i dr.
Izdano: (2015)

DNA binding partners of YAP/TAZ
od: Kim, Min-Kyu, i dr.
Izdano: (2018)

Hippo-YAP/TAZ signaling in angiogenesis
od: Park, Jeong Ae, i dr.
Izdano: (2018)

YAP/TAZ as therapeutic targets in cancer
od: Zanconato, Francesca, i dr.
Izdano: (2016)

Mechanobiology of YAP and TAZ in physiology and disease
od: Panciera, Tito, i dr.
Izdano: (2017)

The emerging role of YAP/TAZ in mechanotransduction
od: Mohri, Zahra, i dr.
Izdano: (2017)

YAP and TAZ regulate cell volume
od: Perez-Gonzalez, Nicolas A., i dr.
Izdano: (2019)

Mechanisms of YAP/TAZ transcriptional control
od: Battilana, Giusy, i dr.
Izdano: (2021)

YAP/TAZ in Bone and Cartilage Biology
od: Zarka, Mylène, i dr.
Izdano: (2022)

YAP/TAZ as therapeutic targets in cancer
od: Francesca Zanconato, i dr.
Izdano: (2016)

Interplay between YAP/TAZ and Metabolism
od: Ja Hyun Koo, i dr.
Izdano: (2018)

Mechanobiology of YAP and TAZ in physiology and disease
od: Tito Panciera, i dr.
Izdano: (2017)

The emerging roles of YAP and TAZ in cancer
od: Toshiro Moroishi, i dr.
Izdano: (2015)

DNA binding partners of YAP/TAZ
od: Min‐Kyu Kim, i dr.
Izdano: (2018)

Hippo-YAP/TAZ signaling in angiogenesis
od: Jeong Ae Park, i dr.
Izdano: (2018)

YAP/TAZ in Bone and Cartilage Biology
od: Mylène Zarka, i dr.
Izdano: (2022)

Mechanisms of YAP/TAZ transcriptional control
od: Giusy Battilana, i dr.
Izdano: (2021)

Nuclear Import and Export of YAP and TAZ
od: Michael Kofler, i dr.
Izdano: (2023)

YAP and TAZ regulate cell volume
od: Nicolas A. Perez-Gonzalez, i dr.
Izdano: (2019)

The emerging role of YAP/TAZ in mechanotransduction
od: Zahra Mohri, i dr.
Izdano: (2017)

The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma
od: Govaere, O, i dr.
Izdano: (2017)

RNA-sequencing-based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers
od: Ceulemans, An, i dr.
Izdano: (2017)

TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex
od: Merritt, Nicole, i dr.
Izdano: (2021)

TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex
od: Nicole Merritt, i dr.
Izdano: (2021)

The Impact of Liver Transplantation after Surgical Treatment of Hepatocellular Carcinoma
od: Topal, Halit, i dr.
Izdano: (2014)